Free Trial

Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of "Moderate Buy" by Analysts

Stevanato Group logo with Medical background

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company.

STVN has been the subject of several research analyst reports. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Stephens raised Stevanato Group to a "strong-buy" rating in a research note on Monday, April 21st. Finally, UBS Group decreased their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a report on Friday, March 7th.

Get Our Latest Analysis on STVN

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of STVN. Whittier Trust Co. purchased a new position in Stevanato Group during the 1st quarter valued at about $27,000. Twin Tree Management LP purchased a new position in Stevanato Group during the 1st quarter valued at about $29,000. Van Berkom & Associates Inc. purchased a new position in Stevanato Group during the 4th quarter valued at about $39,000. Johnson Financial Group Inc. purchased a new position in Stevanato Group during the 4th quarter valued at about $41,000. Finally, SVB Wealth LLC purchased a new position in Stevanato Group during the 1st quarter valued at about $46,000.

Stevanato Group Price Performance

NYSE:STVN traded down €0.47 ($0.53) during trading hours on Friday, hitting €23.27 ($26.44). 274,400 shares of the company's stock traded hands, compared to its average volume of 335,394. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The business's fifty day simple moving average is €22.05 and its two-hundred day simple moving average is €21.50. Stevanato Group has a 52 week low of €16.56 ($18.82) and a 52 week high of €25.75 ($29.26). The firm has a market cap of $7.05 billion, a P/E ratio of 49.51, a P/E/G ratio of 7.18 and a beta of 0.53.

Stevanato Group (NYSE:STVN - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share (EPS) for the quarter, hitting the consensus estimate of €0.20 ($0.23). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million during the quarter, compared to analyst estimates of €346.26 million. On average, research analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Thursday, July 17th. Stockholders of record on Thursday, June 5th will be issued a $0.0613 dividend. The ex-dividend date of this dividend is Thursday, June 5th. This represents a dividend yield of 0.3%. This is an increase from Stevanato Group's previous annual dividend of $0.05. Stevanato Group's payout ratio is currently 11.76%.

About Stevanato Group

(Get Free Report

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Analyst Recommendations for Stevanato Group (NYSE:STVN)

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines